Jaguar Animal Health
Canalevia® -CA1
Canalevia® -CA1
Canalevia-CA1 is an antidiarrheal, enteric-coated tablet for oral administration. It acts locally and it is not absorbed into the blood stream, providing a well tolerated and non-toxic drug product.
VMX | Veterinary Meeting & Expo
VMX | Veterinary Meeting & Expo
Plan to attend VMX 2026, powered by NAVC. It’s the world's premier veterinary event each year with hundreds of hours of CE, the latest products, and more!
Antimicrobial Stewardship Article | AVMA®
Antimicrobial Stewardship Article | AVMA®
Feedback Form
Feedback Form
Cancer in Pets | AVMA®
Cancer in Pets | AVMA®
Pets today have a better chance of being successfully treated for cancer than ever before, thanks to major advances in early recognition, diagnosis, and treatment. Understanding what cancer is—and what signs to look for—can help you act quickly and make informed choices.
dvm360 LIVE!™ Episode with Dr. Sue Cancer Vet
dvm360 LIVE!™ Episode with Dr. Sue Cancer Vet
Boarded oncologist Sue Ettinger walks through a recent oncology case and shares her approach to treating chemotherapy-induced diarrhea in her patient
Webinar Featuring Craig Clifford, DVM, MS, DACVIM
Webinar Featuring Craig Clifford, DVM, MS, DACVIM
Thursday, October 27, 2022 at 8:00 PM Eastern Daylight Time.
VPN Article by Andre Teixeira, DVM, Ph.D.
VPN Article by Andre Teixeira, DVM, Ph.D.
With pet owners increasingly opting to pursue treatment after a cancer diagnosis, the field of veterinary oncology sees consistent growth and investment into better cancer mitigation. As developments in cancer treatment continue, understanding adverse effects of these treatments is expanding. One such common effect is chemotherapy-induced diarrhea (CID) in dogs. While CID is likely already on every veterinary professional’s mind, knowing the specific impact of CID on canine patients’ health outcomes and potential treatment options is crucial for all who treat cancer or provide supportive care for dogs with CID.
PetVet Article by Andre Teixeira, DVM, Ph.D.
PetVet Article by Andre Teixeira, DVM, Ph.D.
Recent advancements in canine chemotherapy have turned what used to be a terminal cancer diagnosis into viable treatment paths for...
A Dog Owner's Guide
A Dog Owner's Guide
Full Package Insert (PI)
Full Package Insert (PI)
VPN Article by Michael Guy DVM, MS, Ph.D.
VPN Article by Michael Guy DVM, MS, Ph.D.
HerbalGram Article
HerbalGram Article
ABC HerbalGram
NPR's Podcast
NPR's Podcast
Facebook
Facebook
LinkedIn
LinkedIn
Jaguar Animal Health | 211 followers on LinkedIn. Plant-based gastrointestinal products for dogs, dairy calves, and foals. | Jaguar Animal Health, a tradename of Jaguar Health (NASDAQ: JAGX), supports the health and well-being of dogs, dairy calves, and foals. Our plant-based gastrointestinal products include Canalevia®-CA1, the only FDA conditionally approved drug to treat chemotherapy-induced diarrhea (CID) in dogs, and our sustainably harvested Neonorm™ Calf and Neonorm™ Foal products for managing dehydration. Jaguar Health is a commercial stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea.
Jaguar Health
Jaguar Health
Learn About Our Key Near-Term Milestones Top line results expected forthcoming for our phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy‑related diarrhea. We are supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of short bowel syndrome and microvillus inclusion disease in the
View on mobile